Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02178228 · ClinicalTrials.gov registry record
Observational Analysis of the Cause of Leaks When Bowel is Cut and Reconnected
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 1,077
- Enrollment target
NCT02178228: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT02178228 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,077 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02178228 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 1,077 participants
- Enrollment target
Study Summary
The purpose of this study is to identify the cause of leaks that sometimes occur after a section of the bowel is removed and reconnected. Certain staplers from the operating room will be collected and sent to a third party (ECRI Institute) to be examined for defects. The patient's charts will be analyzed for medical issues that may contribute to leaks after surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,077 participants |
| Start Date | 2013-10 |
| Est. Completion | 2018-01-31 |
What the finished NCT02178228 record still lists
NCT02178228 is an observational study that tracks outcomes without assigning an intervention. Its 1,077 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02178228 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02178228 about?
NCT02178228 is a clinical study titled "Observational Analysis of the Cause of Leaks When Bowel is Cut and Reconnected". The purpose of this study is to identify the cause of leaks that sometimes occur after a section of the bowel is removed and reconnected. Certain staplers from the operating room will be collected and sent to a third party (ECRI Institute) to be examined for defects. The patient's charts will be ana...
What is the current status of trial NCT02178228?
This trial is currently completed. The enrollment target is 1,077 participants. The study started on 2013-10. Estimated completion is 2018-01-31.
Who is sponsoring clinical trial NCT02178228?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07084883 · 1,076 participants
Pivotal Trial of an Automated AI-based System for Early Diagnosis and Prediction of Late Age-related Macular Degeneration
- NCT06658808 · 1,075 participants · NA
Efficacy-Implementation Study for PC CARES in Rural Alaska
- NCT06074068 · 1,080 participants · NA
Father-Focused Intervention for Reducing Family Violence and Symptoms in Children
- NCT07213804 · 1,080 participants · Phase 3
A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia